Charles River Laboratories | CRL - Stock


Charles River Laboratories reported $346.26M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Agilent USD 1.09B 30M Mar/2026
Align Technology USD 212.24M 2.7M Jun/2026
Bio-Rad Laboratories USD 780.6M 10.1M Jun/2026
Bruker USD 1.12B 1.4M Jun/2026
Cardinal Health USD 18.01B 2.11B Mar/2026
Charles River Laboratories USD 346.26M 13.46M Jun/2026
Cigna USD 5.85B 16M Jun/2026
CVS Health USD 17.62B 148M Jun/2026
Danaher USD 3.26B 652M Jun/2026
Dentsply International USD 665M 6M Jun/2026
Elevance Health USD 0 0 Dec/2024
Illumina USD 629M 18M Jun/2026
Incyte USD 112.54M 3.08M Jun/2026
Intrexon USD 287K 68K Dec/2022
Laboratory Of America USD 562.2M 64.5M Jun/2026
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
McKesson USD 26.26B 2.05B Jun/2026
Merck EUR 4.78B 220M Mar/2026
Mettler Toledo International USD 411.56M 6.74M Jun/2026
Novartis USD 6.22B 66M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Quest Diagnostics USD 233M 8M Jun/2026
Revvity USD 378.5M 9M Jun/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
United Therapeutics USD 193.8M 15.5M Jun/2026
UnitedHealth USD 280M 280M Dec/2023
Waters USD 1.38B 119M Jun/2026
West Pharmaceutical Services USD 447.4M 5.2M Jun/2026